Marco Chacón
Plus aucun poste en cours
Profil
Marco A.
Chacón, Ph.D., serves as the Founder and Chairman of the Board of Paragon Bioservices (acquired by Catalent Corporation, NYSE: CTLT), Inc., one of the country’s largest contract development and GMP manufacturing organizations.
Located at the University of Maryland BioPark in Baltimore, Paragon specializes in the development and GMP manufacturing of viral vectors and vaccines.
Dr. Chacón also serves as the Assistant Vice President of Industry Alliances at the University of Maryland, Baltimore (UMB).
As a biopharmaceutical executive and entrepreneur, Dr. Chacón works with the leadership team at UMB, leading special projects to strengthen the University’s research collaborations with the biopharmaceutical industry by developing university intellectual property projects.
Dr. Chacón received a B.S.
degree from Youngstown State University and a Ph.D.
Degree from the University of Maryland, College Park.
He currently serves on the board of trustees of the University of Maryland, Baltimore (UMB) Foundation and was appointed in 2016 to the Life Sciences Advisory Board by Maryland Governor Lawrence J.
Hogan, Jr.
Postes actifs de Marco Chacón
| Sociétés | Poste | Début |
|---|---|---|
| University of Maryland | Directeur/Membre du Conseil | 01/01/2014 |
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Private Equity Investor | - |
Center For Breakthrough Medicines Holdings LLC
 Center For Breakthrough Medicines Holdings LLC Miscellaneous Commercial ServicesCommercial Services Center For Breakthrough Medicines Holdings LLC is a private company that specializes in gene and cell therapy. The company is based in King of Prussia, PA. The company offers innovative services that are saving lives. The company was founded by Audrey E. Greenberg. | Président | 01/01/2020 |
Anciens postes connus de Marco Chacón
| Sociétés | Poste | Fin |
|---|---|---|
Catalent Maryland, Inc.
 Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Directeur Général | - |
| Greater Baltimore Technology Council, Inc. | Directeur/Membre du Conseil | - |
Psyadon Pharmaceuticals, Inc.
 Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD. | Directeur Général | - |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | - |
Formation de Marco Chacón
| University of Maryland | Doctorate Degree |
| Youngstown State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD. | Retail Trade |
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |
| Greater Baltimore Technology Council, Inc. | Commercial Services |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
Center For Breakthrough Medicines Holdings LLC
Center For Breakthrough Medicines Holdings LLC Miscellaneous Commercial ServicesCommercial Services Center For Breakthrough Medicines Holdings LLC is a private company that specializes in gene and cell therapy. The company is based in King of Prussia, PA. The company offers innovative services that are saving lives. The company was founded by Audrey E. Greenberg. | Commercial Services |
